S-Wire Guidewire System

K153397 · Concert Medical, LLC · DQX · Aug 18, 2016 · Cardiovascular

Device Facts

Record IDK153397
Device NameS-Wire Guidewire System
ApplicantConcert Medical, LLC
Product CodeDQX · Cardiovascular
Decision DateAug 18, 2016
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.1330
Device ClassClass 2

Intended Use

The S-Wire Guidewire System is intended to facilitate the introduction and placement of interventional devices within the chambers of the heart, including those used in trans-catheter aortic valve implantation (TAVI) procedures.

Device Story

S-Wire Guidewire System is a sterile, single-use 0.035" diameter, 260 cm long guidewire. It features a nickel-titanium alloy core with PTFE coating and a 304V stainless steel distal coil with silicone coating. The distal end has a pre-formed double curve (360° bend, ~3 cm diameter) with a small S-curve at the tip to provide an atraumatic shape. Used in clinical settings (e.g., cath labs) by physicians to facilitate the introduction and placement of interventional devices within the aorta and heart chambers during TAVI procedures. Includes a 9 Fr disposable plastic introducer to aid loading into intravascular catheters. The device provides a stable track for interventional tools, potentially improving procedural success and patient outcomes during cardiac interventions.

Clinical Evidence

Bench testing only. No clinical data. Testing included dimensional inspection, tensile strength, distal loop compression force, distal tip shape retention, tip stiffness, coating integrity, particulate evaluation, catheter compatibility, flex testing, fracture testing, and corrosion resistance per FDA guidance and ISO 11070. Biocompatibility testing (cytotoxicity, irritation, sensitization, acute systemic toxicity, hemocompatibility, pyrogen) and sterile package integrity testing were performed per ISO 10993. Results met all predetermined acceptance criteria.

Technological Characteristics

Nickel-titanium superelastic alloy core; 304V stainless steel distal coil; PTFE shaft coating; silicone distal coil coating. 0.035" diameter; 260 cm length. Pre-formed double-curve distal tip. Ethylene Oxide sterilization (ISO 10993-7). Includes 9 Fr plastic introducer. Mechanical device; no software or energy source.

Indications for Use

Indicated for patients undergoing interventional procedures within the heart chambers, including trans-catheter aortic valve implantation (TAVI).

Regulatory Classification

Identification

A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.

Special Controls

*Classification.* Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/13 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, with three figures in profile facing right. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 August 18, 2016 Concert Medical, LLC % Pamela Papineau President Delphi Medical Device Consulting, Inc. 5 Whitcomb Ave Ayer, Massachusetts 01432 Re: K153397 Trade/Device Name: S-Wire Guidewire System Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: DOX Dated: November 17, 2015 Received: November 24, 2015 Dear Ms. Papineau: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device {1}------------------------------------------------ related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely vours. M. A. Hilleman for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K153397 Device Name S-Wire Guidewire System Indications for Use (Describe) The S-Wire Guidewire System is intended to facilitate the introduction and placement of interventional devices within the chambers of the heart, including those used in trans-catheter aortic valve implantation (TAVI) procedures. Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # 510(k) Summary - Revised (Clean Copy) | Date Prepared: | 15 July 2016 | |-------------------------|---------------------------------------------------------------------------------------------------------------------| | General Information | | | Owner's Name: | Concert Medical, LLC | | Address: | 77 Accord Park Drive<br>Norwell, MA 02061 | | Telephone: | 781-871-7882 | | Fax: | 781-724-4555 | | Contact Person: | Pamela Papineau, RAC (US, EU, CAN)<br>Delphi Medical Device Consulting, Inc.<br>5 Whitcomb Avenue<br>Ayer, MA 01432 | | Telephone: | (978) 772-3552 | | Fax: | (978) 796-5460 | | Subject Device: | | | Trade Name: | S-Wire Guidewire System | | Common Name: | Catheter Guide Wire | | Product Code: | DQX | | FDA Regulation: | 21 CFR 870.1330 - Catheter Guide Wire | | Device Classification: | Class II | | Predicate Device: | | | Product Name: | Lake Region Pre-Formed Guidewire (Boston Scientific Safari<br>Pre-Shaped TAVI Guidewire) | | Common Name: | Catheter Guide Wire | | Product Code: | DQX | | FDA Regulation: | 21 CFR 870.1330 - Catheter Guide Wire | | Device Classification: | Class II | | Premarket Notification: | K130798, K151244 | | Indications for Use | | The S-Wire Guidewire System is intended to facilitate the introduction and placement of interventional devices within the chambers of the heart, including those used in trans-catheter aortic valve implantation (TAVI) procedures ### Device Description: The S-Wire Guidewire System is a sterile, single-use guidewire used for the placement of interventional devices within the aorta and the chambers of the heart. The S-Wire has a 0.035" diameter, and an overall length of 260 cm. The S-Wire construction consists of a nickel-titanium alloy core wire that is PTFE coated, ground and thermally formed. The S-Wire distal coil is {4}------------------------------------------------ made of 304V stainless steel: the distal and proximal ends of the stainless steel coil is bonded to the core wire. The distal portion of the S-Wire has silicone coating. The distal end of the S-Wire has a pre-formed double curve shape consisting of an approximately 360° bend with an outer diameter of approximately 3 cm, and a small S-curve at the distal tip of the wire that is fully contained within the 3 cm curved area. The S-Wire Guidewire System includes a disposable plastic 9 Fr introducer (6 inches long) that is used as an aid in loading the S-Wire into an intravascular catheter. ## Substantial Equivalence The Concert Medical S-Wire Guidewire System is substantially equivalent to the Lake Region Pre-Formed Guidewire (K151244 & K130798), which is marketed by Boston Scientific Corp. as the Safari Pre-Shaped TAVI guidewire. Substantial equivalence, which is summarized below, is based on indications for use, physical and technological characteristics, and comparative device testing. | | Concert Medical S-Wire Guidewire<br>System (current submission) | Lake Region Pre-Formed Guidewire<br>(K151244 & K130798) | |----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Common/Usual Name | Catheter Guide Wire | Catheter Guide Wire | | Device Class | Class II | Class II | | Product Code / Regulation | DQX / 21 CFR 870.1300 | DQX / 21 CFR 870.1300 | | Regulation Name | Catheter Guide Wire | Catheter Guide Wire | | Prescription Use | Rx Only | Rx Only | | Indications for Use | To facilitate the introduction and<br>placement of interventional devices<br>within the chambers of the heart,<br>including those used in trans-catheter<br>aortic valve implantation (TAVI)<br>procedures | To facilitate the introduction and<br>placement of interventional devices<br>within the chambers of the heart,<br>including those used within trans-<br>catheter aortic valve procedures | | Guidewire OD | 0.035" | 0.035" | | Guidewire Length | 260 cm | 260 cm – 300 cm | | Guidewire Materials | Nickel-titanium superelastic alloy,<br>304V stainless steel, adhesive | A313 stainless steel | | Guidewire Coating | PTFE (shaft); Silicone (distal coil) | PTFE | | Tip Shape | Atraumatic double curve | Atraumatic double curve | | Sterile Device? | Yes | Yes | | Sterilization Type | Ethylene Oxide | Ethylene Oxide | | EO Sterilization Residuals | Per ISO 10993-7 | Per ISO 10993-7 | | Disposable / Reusable | Disposable | Disposable | ## Performance Testing: Performance testing for the Concert Medical S-Wire Guidewire System consists of the measurement of physical characteristics and device integrity in accordance with FDA's Coronary and Cerebrovascular Guidewire Guidance and ISO 11070 (Sterile, single-use intravascular catheter introducers); testing included dimensional inspection, tensile strength (guidewire and introducer), distal loop compression force, distal tip shape retention, tip stiffness, coating integrity, particulate evaluation, catheter compatibility, guidewire flex testing, guidewire fracture testing and corrosion resistance. Where applicable, comparative test results are provided {5}------------------------------------------------ for the S-Wire and the predicate device. Additional testing included in this Premarket Notification includes ISO 10993 biocompatibility testing (cytotoxicity, irritation, sensitization, acute systemic toxicity, hemocompatibility and pyrogen) and sterile package integrity testing (pouch seal tensile strength and dye penetration). The Concert Medical S-Wire Guidewire System met all predetermined acceptance criteria and compared favorably with the predicate device. ## Conclusion: The Concert Medical S-Wire Guidewire System has been demonstrated to be substantially equivalent to the predicate device.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%